The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Innate Pharma competitive analysis

Loading summary...

Latest patents of Innate Pharma opposed by its competitors

Explore Innate Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP4096717
Dec 11, 2024Treatment Of Cancer2
EP3405495
Feb 24, 2021Neutralization Of Inhibitory Pathways In Lymphocytes1
EP3191517
Nov 4, 2020Cross Reactive Siglec Antibodies1

Latest PTAB cases involving Innate Pharma

Discover the latest PTAB cases involving Innate Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Innate Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INNATE PHARMA - 4 - -
ARROWHOUSE7 - - -
GRAF VON STOSCH4 - - -
HOIBERG PS2 - - -